DEJONGE, Boudewijn, Lodewijk Maria,DURAND-REVILLE, Thomas, Francois,VERHEIJEN, Jeroen, Cunera,TOMMASI, Ruben,MUELLER, John
申请号：
HK18104155
公开号：
HK1244798B
申请日:
2018.03.26
申请国别(地区):
HK
年份:
2020
代理人:
摘要：
The present invention is directed to combinations of a β-lactamase inhibitor with sulbactam and, optionally, imipenem/cilastatin. The combinations are useful for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant pathogens. More particularly, the invention relates to a combination of β-lactamase inhibitor compound 1 : or a pharmaceutically acceptable salt thereof, with sulbactam, or a pharmaceutically acceptable salt thereof, and, optionally, imipenem/cilastatin, or a pharmaceutically acceptable salt thereof.
